Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Specialty Chemicals

Jubilant Ingrevia Limited engages in the life science products and solutions in India, the United States, Europe, China and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition health solutions. The Chemical intermediates segment offers acetyls and specialty ethanol. The company provides piperidines, metal complexes, choline salts, vitamin B3, Vitamin B4, picolinates, riboflavin phosphate sodium, nutritional premixes, antioxidants, straight ingredients, acetic anhydride, acetic acid, ethyl acetate, propionic anhydride, formaldehyde, bio acetic acid-food grade, acetaldehyde, and ethanol, as well as cyano, acetyl, amino, halo, alkyl, and aldehyde pyridines. In addition, it offers route design, process development, process optimization, and scale-up and commercial manufacturing of intermediates. Further, the company provides vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, animal and human nutrition, agrochemical, personal and consumer care, and industrial customers. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is headquartered in Noida, India.

Revenue projections:

Revenue projections for JUBLINGREA
Revenue projections for JUBLINGREA

Investors are expected to be cautious with JUBLINGREA, as its revenues are projected to fall compared to last year. A decline in revenue often results in a negative impact on profitability, prompting concerns about the company's financial stability and making investors more conservative in their approach.

Financial Ratios:

currentRatio 0.000000
forwardPE 25.747272
debtToEquity 26.094000
earningsGrowth 0.542000
revenueGrowth 0.013000
grossMargins 0.393090
operatingMargins 0.097600
trailingEps 17.520000
forwardEps 0.000000

Jubilant Ingrevia Limited's Forward PE is in a favorable range, suggesting the stock is reasonably priced relative to its earnings. This indicates the stock is not overpriced, providing room for potential growth and making it an attractive option for investors looking for solid value and future upside.
Jubilant Ingrevia Limited's low Debt-to-Equity ratio indicates the company is not over-leveraged. This suggests a balanced financial structure with limited reliance on debt, which reduces financial risk and enhances its stability, making Jubilant Ingrevia Limited's financial position more secure and appealing to investors.

Price projections:

Price projections for JUBLINGREA
Price projections for JUBLINGREA

Over time, Jubilant Ingrevia Limited's price projections have been revised higher, signaling growing confidence in the company's future. This upward trend suggests analysts anticipate strong performance and increased market value for Jubilant Ingrevia Limited.

Insider Transactions:

Insider Transactions for JUBLINGREA
Insider Transactions for JUBLINGREA


2 JUBLINGREA sales were executed, with market price at 686.4500122070312.9 buy transactions of JUBLINGREA stock were completed, with market price at 721.272230360243.Investors have been purchasing Jubilant Ingrevia Limited more than selling it at current price levels, which may reflect optimism. This pattern suggests that the market expects favorable outcomes for the stock, leading to increased buying interest.

Recommendation changes over time:

Recommendations trend for JUBLINGREA
Recommendations trend for JUBLINGREA


Analysts have shown a buy bias for Jubilant Ingrevia Limited, signaling it as a strong investment choice. This positive outlook could motivate investors to allocate funds to Jubilant Ingrevia Limited, seeing it as a reliable and potentially profitable option, especially in an environment where the stock market is highly scrutinized.